Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
AbbVie Oy
OY
Active
Y-tunnus 2470310-6
Pasilan Asema-Aukio 1, 00520
Helsinki
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2012
108 employees
Watchlist
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
AbbVie Oy
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (1)
BK
Baedr Kayali
Chief Executive Officer
Chief Executive Officer
2025
Former (3)
BK
Bernd Krones
Chief Executive Officer
Chief Executive Officer
2023 – 2025
HR
Hanna Reetta Katariina Kaskimies
Audit
Audit
2013 – 2023
MR
Matthew Robert Iles
Chief Executive Officer
Chief Executive Officer
2019 – 2023
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (3)
PM
Päivi Margarita Kiiski
Board of Directors
2025
AJ
Arnaud Jean Jacques Coint-Bavarot
Board of Directors
2022
SI
Shitra Irari Amozurrutia
Board of Directors
2024
Former (4)
AK
Anne Katariina Lehtonen
Board of Directors
2018 – 2019
EC
Emilie Claudine Demare
Board of Directors
2022 – 2024
WJ
William Joseph Chase
Board of Directors
2018 – 2019
RA
Robert Andrew Michael
Board of Directors
2019 – 2022
Aktionærer
Pr. seneste årsrapport
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on AbbVie Oy
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network